Continuous subcutaneous insulin infusion versus multiple daily injections of insulin for pregnant women with diabetes
Referencias
Additional references
Alderson P, Green S, Higgins JPT, editors. Cochrane Reviewers' Handbook 4.2.2 [updated March 2004]. In: The Cochrane Library, Issue 1, 2004. Chichester, UK: John Wiley & Sons, Ltd.
Anderson JH, Brundelle RL, Koivisto VA. Reduction of postprandial hyperglycaemia and frequency of hypoglycaemia in IDDM patients on insulin analog treatment. Multicentre insulin Lispro Study Group. Diabetes 1997;46:265‐70.
Brink SJ, Stewart C. Insulin pump treatment in insulin‐dependent diabetes mellitus. JAMA 1986;255(5):617‐21.
Buhling KJ, Kurzidim B, Wolhlfarth K, Mahmoudi M, Wascher C, Siebert G, et al. Introductory experience with the continuous glucose monitoring system (CGMS; Medtronic Minimed) in detecting hyperglycaemia by comparing the self monitoring of blood glucose (SMBG) in non‐pregnant women and pregnant women with impaired glucose tolerance and gestational diabetes. Experimental and Clinical Endocrinology & Diabetes 2004;112(10):556‐60.
Casson IF, Clarke CA, Howard CV, McKendrick O, Pennycook S, Pharoah POD, et al. Outcomes of pregnancy in insulin dependent diabetic women: results of a five year population cohort study. BMJ 1997;315:275‐8.
Maternal and Child Health Research Consortium. Confidential enquiry into stillbirths and deaths in infancy. 8th Annual Report, 1 January‐31 December 1999.2001.
Colquitt JL, Green C, Sidhu MK, Hartwell D, Waugh N. Clinical and cost effectiveness of continuous subcutaneous insulin infusion for diabetes. Health Technology Assessment Programme 2004;8(9):43.
Department of Health. Current and future research on diabetes: a review for the DOH and MRC. www.doh.gov.uk/nsf/diabetes/research (accessed 2002).
Gonzalez JL. Management of diabetes in pregnancy. Clinical Obstetrics and Gynecology 2002;45(1):165‐9.
Hadden DR. The management of diabetes in pregnancy. Postgraduate Medical Journal 1996;72:525‐31.
Hawthorne G, Robson S, Ryall EA, Sen D, Roberts SH, Ward Platt MP. Prospective population based survey of outcome of pregnancy in diabetic women: results of the Northern diabetic pregnancy audit, 1997. BMJ 1997;315:279‐81.
Hawthorne G, Modder J. Maternity services for women with diabetes in the UK. BMJ 2002;19(Suppl 4):50‐5.
Hirsch IB, Bode BW, Garg S, Lane WS, Sussman A, Hu P, et al. Continuous subcutaneous insulin infusion (CSII) of insulin aspart versus multiple daily injection of insulin aspart/insulin glargine in type 1 diabetic patients previously treated with CSII. Diabetes Care 2005;28(3):533‐8.
Johansson UB, Adamson UC, Lins PE, Wredling RA. Improved blood glucose variability, HbA1C insuman infusat and less insulin requirement in IDDM patients using insulin lispro in CSII. The Swedish Multicentre Lispro Insulin Study. Diabetes and Metabolism 2000;26:192‐6.
John WG. Glycated haemoglobin analysis. Annals of Clinical Biochemistry 1997;34:17‐31.
Kerssen A, De‐Valk HW, Visser GHA. The continuous monitoring system during pregnancy of women with type 1 diabetes mellitus: accuracy assessment. Diabetes Technology & Therapeutics 2004;6(5):645‐51.
Kilpatrick ES. Problems in the assessment of glycaemic control in diabetes mellitus. Diabetic Medicine 1997;14:819‐31.
Kilpatrick ES, Maylor PW, Keevil BG. Biological variation of glycated haemoglobin. Diabetes Care 1998;21(2):261‐4.
Knight G, Jennings AM, Boulton AJM, Tomlinson S, Ward JD. Severe hyperkalaemia and ketoacidosis during routine treatment with an insulin pump. BMJ 1985;291:371‐2.
Langer O, Conway DL. Level of glycaemia and perinatal outcome in pregestational diabetes. Journal of Maternal‐Fetal medicine 2000;9:35‐41.
Maresh M. Diabetes in pregnancy. Current Opinion in Obstetrics and Gynecology 2001;13:103‐7.
Marshall SM, Barth JH. Standardization of HbA1c measurements‐a consensus statement. Diabetic Medicine 2000;17:5‐6.
Mecklenburg RS, Benson EA, Benson JW, Fredlund PN, Guinn T, Metz RJ, et al. Acute complications associated with insulin infusion pump therapy. Report of experience with 161 patients. JAMA 1984;252(23):3265‐69.
Pickup J, Mattock M, Kerry S. Glycaemic control with continuous subcutaneous insulin infusion compared with intensive insulin injections in patients with type 1 diabetes: meta‐analysis of randomised controlled trials. BMJ 2002;324:705‐8.
Porter H, Belfort MA. Evaluation of a new real‐time continuous glucose monitoring system in pregnant women without gestational diabetes: a pilot study. Journal of Perinatal and Neonatal Nursing 2004;18(2):93‐102.
The Cochrane Collaboration. Review Manager (RevMan). Version 4.2 for Windows. Oxford, England: The Cochrane Collaboration, 2003.
Siebenhofer A, Plank J, Berghold A, Horvath K, Sawicki PT, Beck P, et al. Meta‐analysis of short‐acting insulin analogues in adult patients with type 1 diabetes: continuous subcutaneous insulin infusion versus injection therapy. Diabetologia 2004;47:1895‐905.
Siebenhofer A, Plank J, Berghold A, Narath M, Gfrerer R, Pieber TR. Short acting insulin analogues versus regular human insulin in patients with diabetes mellitus. The Cochrane Database of Systematic Reviews 2004, Issue 4.
Walkinshaw SA. Very tight versus tight control for diabetes in pregnancy. The Cochrane Database of Systematic Reviews 1996, Issue 3.
Williams J. Overview of the care of pregnant women with pre‐existing diabetes. Journal of Diabetes Nursing 2003;7:12‐6.
